Guwahati News Desk: Despite European Medicines Agency (EMA) recommendation as ‘the vaccine is safe for use’, the Finnish Institute for Health and Welfare (THL) on Friday announced a one-week suspension of the AstraZeneca’s Covid-19 vaccine in the country.
Two probable cases of blood clots have been reported in Finland among people who have taken the vaccine.
Both patients also had underlying medical conditions.
Hanna Nohynek, the chief physician at the THL, said at a press conference that no causal link had been established. The one-week suspension was decided as a precautionary measure.
Nohynek added that the decision was also based on similar cases reported in Norway, Denmark and Germany.
The THL said, “The suspension took effect immediately and the use of the AstraZeneca vaccine could resume on March 29 at the earliest.”